BIOMAT Database Logo BIOMAT Database Logo

Comparative in vitro activity of Bay k 4999 and piperacillin. 1979

J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D001390 Azlocillin A semisynthetic ampicillin-derived acylureido penicillin. Azlin,Azlocillin Sodium,Bay-e 6905,Securopen,Sodium Azlocillin,Azlocillin, Sodium,Bay e 6905,Baye 6905,Sodium, Azlocillin
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D048289 Imidazolidines Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring. Imidazolidine

Related Publications

J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
June 1979, Antimicrobial agents and chemotherapy,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
October 1978, Antimicrobial agents and chemotherapy,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
January 1980, Infection,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
August 1979, Antimicrobial agents and chemotherapy,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.
May 1979, Antimicrobial agents and chemotherapy,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Comparative activity in vitro of piperacillin.
February 1982, The Journal of antimicrobial chemotherapy,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
January 1983, Current medical research and opinion,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Determination of the ureidopenicillins azlocillin, mezlocillin and bay K 4999 in plasma by high performance liquid chromatography.
December 1979, British journal of clinical pharmacology,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Comparative in vitro activity of piperacillin, piperacillin-sulbactam and piperacillin-tazobactam against nosocomial pathogens isolated from intensive care patients.
November 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
J B Malow, and V M Zimelis, and H Pahlavanzadeh, and G W White, and A P Panwalker, and G G Jackson
Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates.
October 1990, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!